Aims: To estimate the prevalence of tumor spread to the parametrium, vagina and uterine corpus in radical hysterectomy specimens and define a subgroup of patients with low-risk of extracervical involvement, who may benefit from less radical surgery. Methods: We retrospectively reviewed 96 patients with stage IA1-IIA cervical cancer who had undergone radical hysterectomy and pelvic lymphadenectomy. Results: Tumor spread beyond the uterine cervix was evident in 45 (47%) patients. Thirteen (13%) of the 96 patients had parametrial tumor spread, 12 (13%) had vaginal tumor extension, and 23 (24%) had uterine corpus involvement. Tumor size >2 cm, stromal invasion to a depth of ≥8 mm, and lymph vascular space invasion (LVSI) were significantly associated with extracervical invasion. Twenty-five patients had stromal invasion of <8 mm and no LVSI, of which only 1 (4%) had extracervical involvement. On the contrary, extracervical involvement was evident in 44 patients (63%) among those who had stromal invasion of ≥8 mm and/or LVSI (p < 0.001). Among women with LVSI, extracervical tumor spread was seen with any tumor size and any depth of stromal invasion. All patients with stromal invasion to a depth of >15 mm had extracervical invasion. Conclusion: Patients with tumor size <2 cm, depth of invasion of <8 mm and no LVSI could be considered for less radical surgery.

Keywords:
Cervical cancer surgery, Radical hysterectomy, Malignancy
1.
Kinney WK, Hodge DO, Egorshin EV, Ballard DJ, Podratz KC: Identification of low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol 1995;57:3-6.
2.
Low JA, Mauger GM, Carmichael JA. The effect of Wertheim hysterectomy upon bladder and urethral function. Am J Obstet Gynecol 1981;139:826-830.
3.
Kodama J, Kusumoto T, Nakamura K, Seki N, Hongo A, Hiramatsu Y: Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery. Gynecol Oncol 2011;122:491-494.
4.
Kim MK, Kim JW, Kim MA, Kim HS, Chung HH, Park NH, Park IA, Song YS, Kang SB: Feasibility of less radical surgery for superficially invasive carcinoma of the cervix. Gynecol Oncol 2010;119:187-191.
5.
Forney JP: The effect of radical hysterectomy on bladder physiology. Am J Obstet Gynecol 1980;138:374-382.
6.
Stegeman M, Louwen M, Velden J, Kate FJW, Bakker MA, Burger CW, Ansink AC: The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol 2007;105:475-480.
7.
Menczer J: A trend toward more conservative surgery in gynecologic oncology. Obstet Gynecol Surv 1996;51:628-636.
8.
Creasman WT, Feter BF, Clarke Pearson DL, Kaufmann L, Parker RT: Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-172.
9.
Morris M, Mitchell MF, Silva EG, Copeland LJ, Gershenson DM: Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-196.
10.
Ueki M, Okamoto Y, Misaki O, Seiki Y, Kitsuki K, Ueda M, Sugimoto O: Conservative therapy for microinvasive carcinoma of the uterine cervix. Gynecol Oncol 1994;53:109-113.
11.
Haller H, Krasevic M, Mamula O, Brncic-Fischer A, Eminovic S, Manestar M: Treatment and outcome of stage IA1 squamous cell carcinoma of the uterine cervix. Int J Gynecol Obstet 2011;113:72-75.
12.
Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Dos Reis R, Levenback CF, Ramirez PT: Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol 2009;114:93-99.
13.
Pluta M, Rob L, Charvat M, Chmel R, Halaska M Jr, Skapa P, Robova H: Less radical surgery than radical hysterectomy in early stage cervical cancer - a pilot study. Gynecol Oncol 2009;113:181-184.
14.
Naik R, Cross P, Nayar A, Matadevi S, Lopes A, Godfrey K, Hatem H: Conservative surgical management of small-volume stage IB1 cervical cancer. BJOG 2007;114:958-963.
15.
Abu-Rustum NR, Neubauer N, Sonoda Y, Park KJ, Gemignani M, Alektiar KM, Tew W, Leitao MM, Chi DS, Barakat RR: Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol Oncol 2008;11:261-264.
16.
Kim JH, Park JY, Kim DY, Kim YM, Kim YT, Nam JH: Fertility-sparing laparoscopic radical trachelectomy for young women with early stage cervical cancer. BJOG 2010;117:340-347.
17.
Cibula D, Slama J, Svarovsky J, Fischerova D, Freitag P, Zikan M, Pinkavova I, Pavlista D, Dundr P: Abdominal radical trachelectomy as fertility-sparing treatment of early-stage cervical cancer. Int J Gynecol Cancer 2009;19:1407-1411.
18.
Beiner ME, Covens A: Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract 2007;4:353-361.
19.
Plante M, Gregoire J, Renaud MC, Roy M: The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol 2011;121:290-297.
20.
Maneo A, Sideri M, Scambia G, Boveri S, dell'Anna T, Villa M, Parma G, Fagotti A, Fanfani F, Landoni F: Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. Gynecol Oncol 2011;123:557-560.
21.
Biliatis I, Kucukmetin A, Patel A, Ratnavelu N, Cross P, Chattopadhyay S, Galaal K, Naik R: Small volume stage 1B1 cervical cancer. Is radical surgery still necessary? Gynecol Oncol 2012;126:73-77.
22.
Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P: How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 2002;84:145-149.
23.
Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, Rader JS, Mutch DG: Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 2007;110:1281-1286.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.